Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Randomized, Controlled, Double-Masked Clinical Trial to Evaluate the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease (The ONSET Study)-Long Term Safety Follow-up

NCT03920215 is registered in ClinicalTrials.gov with Oyster Point Pharma, Inc. as lead sponsor.

NCT NCT03920215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03920215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Randomized, Controlled, Double-Masked Clinical Trial to Evaluate the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease (The ONSET Study)-Long Term Safety Follow-up
Lead sponsor
Oyster Point Pharma, Inc.
Phase
Phase 2/3
Overall status
Completed
Start date
August 15, 2018
Completion date
September 20, 2019
Enrollment
101 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

long term follow up dry eye disease